{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:54:15Z","timestamp":1792403655157,"version":"4.4.0"},"reference-count":133,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Osteoporosis and chronic conditions such as type 2 diabetes mellitus, cardiovascular disease, heart failure, and chronic kidney disease share several common biological mechanisms, including chronic inflammation, oxidative stress, hormonal dysregulation, and metabolic alterations. In this context, multimorbidity presents an increasing clinical challenge, particularly in older populations, where osteoporosis remains frequently underdiagnosed and undertreated. This review aims to explore the complex interplay between skeletal fragility and cardiometabolic diseases, emphasizing the role of nutritional deficiencies (such as iron and vitamin C), shared molecular pathways (advanced glycation end-products, Renin\u2013Angiotensin\u2013Aldosterone System, RANK Ligand, RANK), and the systemic impact of chronic inflammation and tissue hypoperfusion. The review also addresses the effects of various drug classes\u2014antidiabetics, antihypertensives, anticoagulants, and anti-osteoporotic agents\u2014on bone metabolism and cardiovascular risk. Special focus is given to the implementation of integrated and personalized care models, particularly multidisciplinary team-based approaches, which have demonstrated significant reductions in mortality and refracture rates, despite their still limited adoption in clinical practice. In conclusion, this review highlights the shared mechanisms between osteoporosis and cardiometabolic conditions in the context of multimorbidity, underscoring persistent clinical challenges related to diagnosis, drug interactions, and care fragmentation that warrant further research into integrated care models.<\/jats:p>","DOI":"10.3390\/nu18020262","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:04:22Z","timestamp":1768392262000},"page":"262","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Underlying Mechanisms of Osteoporosis in the Context of Multimorbidity: Clinical Challenges and Management Strategies"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9136-2055","authenticated-orcid":false,"given":"Alberto","family":"Castagna","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8854-5854","authenticated-orcid":false,"given":"Carmelo","family":"Pujia","sequence":"additional","affiliation":[{"name":"O.U. Clinical Nutrition, Renato Dulbecco Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-7090","authenticated-orcid":false,"given":"Elisa","family":"Mazza","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7644-1337","authenticated-orcid":false,"given":"Samantha","family":"Maurotti","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7503-6188","authenticated-orcid":false,"given":"Yvelise","family":"Ferro","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Rizzo","sequence":"additional","affiliation":[{"name":"O.U. Clinical Nutrition, Renato Dulbecco Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Formica","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosy","family":"Conforto","sequence":"additional","affiliation":[{"name":"O.U. Clinical Nutrition, Renato Dulbecco Hospital, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0949-4900","authenticated-orcid":false,"given":"Caterina","family":"Mercuri","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1674-5317","authenticated-orcid":false,"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"},{"name":"Research Center for the Prevention and Treatment of Metabolic Diseases, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9974-0735","authenticated-orcid":false,"given":"Carmine","family":"Gazzaruso","sequence":"additional","affiliation":[{"name":"Diabetes and Endocrine and Metabolic Diseases Unit, Centre for Applied Clinical Research (Ce.R.C.A.), Clinical Institute \u201cBeato Matteo\u201d (Hospital Group San Donato), 27029 Vigevano, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Pujia","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"},{"name":"Research Center for the Prevention and Treatment of Metabolic Diseases, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7048-5830","authenticated-orcid":false,"given":"Tiziana","family":"Montalcini","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"},{"name":"Research Center for the Prevention and Treatment of Metabolic Diseases, University \u201cMagna Gr\u00e6cia\u201d of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2633556521993993","DOI":"10.1177\/2633556521993993","article-title":"Comorbidity Versus Multimorbidity: Why it Matters","volume":"11","author":"Harrison","year":"2021","journal-title":"J. Multimorb. Comorbidity"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"101860","DOI":"10.1016\/j.eclinm.2023.101860","article-title":"Global and Regional Prevalence of Multimorbidity in the Adult Population in Community Settings: A Systematic Review and Meta-Analysis","volume":"57","author":"Chowdhury","year":"2023","journal-title":"EClinicalMedicine"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11657-021-00969-8","article-title":"Osteoporosis in Europe: A Compendium of Country-Specific Reports","volume":"17","author":"Willers","year":"2022","journal-title":"Arch. Osteoporos."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","article-title":"SCOPE 2021: A New Scorecard for Osteoporosis in Europe","volume":"16","author":"Kanis","year":"2021","journal-title":"Arch. Osteoporos."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","article-title":"Fragility Fractures in Europe: Burden, Management and Opportunities","volume":"15","author":"Borgstrom","year":"2020","journal-title":"Arch. Osteoporos."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.drudis.2020.06.016","article-title":"Treating Age-Related Multimorbidity: The Drug Discovery Challenge","volume":"25","author":"Ermogenous","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Corsonello, A., Fabbietti, P., Formiga, F., Moreno-Gonzalez, R., Tap, L., Mattace-Raso, F., Roller-Wirnsberger, R., Wirnsberger, G., Arnlov, J., and Carlsson, A.C. (2020). Chronic Kidney Disease in the Context of Multimorbidity Patterns: The Role of Physical Performance: The Screening for CKD among Older People Across Europe (SCOPE) Study. BMC Geriatr., 20.","DOI":"10.1186\/s12877-020-01696-4"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Liu, X., Chen, F., Liu, L., and Zhang, Q. (2023). Prevalence of Osteoporosis in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis of Observational Studies. BMC Endocr. Disord., 23.","DOI":"10.1186\/s12902-022-01260-8"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nardone, I., Antonelli, R., Zaccaria, S., Wolde Sellasie, S., Falcone, S., Pecchioli, C., Giurato, L., and Uccioli, L. (2024). Prevalence of Diabetes Mellitus and Clinical Differences in Patients with Severe Osteoporosis and Fragility Fractures. J. Clin. Med., 13.","DOI":"10.3390\/jcm13092670"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.nefro.2023.05.002","article-title":"Osteoporosis Management in Patients with Chronic Kidney Disease (ERCOS Study): A Challenge in Nephrological Care","volume":"44","author":"Bover","year":"2024","journal-title":"Nefrolog\u00eda"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00198-022-06598-2","article-title":"Prevalence of Low Bone Mineral Density (T-Score \u2264 \u22122.5) in the Whole Spectrum of Chronic Kidney Disease: A Systematic Review and Meta-Analysis","volume":"34","author":"Duarte","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jbmr.2017","article-title":"A Meta-Analysis of the Association of Fracture Risk and Body Mass Index in Women","volume":"29","author":"Johansson","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"155638","DOI":"10.1016\/j.metabol.2023.155638","article-title":"Sarcopenia, Osteoporosis and Frailty","volume":"145","author":"Gielen","year":"2023","journal-title":"Metab. Clin. Exp."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/jbmr\/zjaf091","article-title":"Body Mass Index and Subsequent Fracture Risk: A Meta-Analysis to Update FRAX","volume":"40","author":"Harvey","year":"2025","journal-title":"J. Bone Miner. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Mohammadian Khonsari, N., Khashayar, P., Shahrestanaki, E., Kelishadi, R., Mohammadpoor Nami, S., Heidari-Beni, M., Esmaeili Abdar, Z., Tabatabaei-Malazy, O., and Qorbani, M. (2022). Normal Weight Obesity and Cardiometabolic Risk Factors: A Systematic Review and Meta-Analysis. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.857930"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100045","DOI":"10.1016\/j.intcar.2021.100045","article-title":"Managing Patients with Multimorbidity","volume":"5","author":"Wilkinson","year":"2021","journal-title":"Clin. Integr. Care"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s00198-018-4759-3","article-title":"A Systematic Review of Factors Affecting Medication Adherence among Patients with Osteoporosis","volume":"29","author":"Yeam","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00198-023-06789-5","article-title":"Osteoporosis Medication Adherence Tools: A Systematic Review","volume":"34","author":"Hesari","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/jendso\/bvab048.505","article-title":"Multimorbidity Increases Risk of Osteoporosis Under-Diagnosis and Under-Treatment in Patients at High Fracture Risk: 45 and Up a Prospective Population Based-Study","volume":"5","author":"Bliuc","year":"2021","journal-title":"J. Endocr. Soc."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bliuc, D., Tran, T., Chen, W., Alarkawi, D., Alajlouni, D.A., Blyth, F., March, L., Ensrud, K.E., Blank, R.D., and Center, J.R. (2023). The Association between Multimorbidity and Osteoporosis Investigation and Treatment in High-Risk Fracture Patients in Australia: A Prospective Cohort Study. PLoS Med., 20.","DOI":"10.1371\/journal.pmed.1004142"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in Bone Mineral Density and Fracture Risk in Patients with Type 1 and Type 2 Diabetes\u2014A Meta-Analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos. Int."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.maturitas.2014.08.003","article-title":"Increased Fracture Risk in Patients with Type 2 Diabetes Mellitus: An Overview of the Underlying Mechanisms and the Usefulness of Imaging Modalities and Fracture Risk Assessment Tools","volume":"79","author":"Savelberg","year":"2014","journal-title":"Maturitas"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/TCRM.S131945","article-title":"Fracture Risk in Patients with Type 2 Diabetes Mellitus and Possible Risk Factors: A Systematic Review and Meta-Analysis","volume":"13","author":"Moayeri","year":"2017","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bone.2019.04.017","article-title":"Risk Factors for Fragility Fractures in Type 1 Diabetes","volume":"125","author":"Leanza","year":"2019","journal-title":"Bone"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e024067","DOI":"10.1136\/bmjopen-2018-024067","article-title":"Diabetes Mellitus and the Risk of Fractures at Specific Sites: A Meta-Analysis","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/dme.12734","article-title":"Type 1 Diabetes and Risk of Fracture: Meta-Analysis and Review of the Literature","volume":"32","author":"Shah","year":"2015","journal-title":"Diabet. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4239\/wjd.v12.i6.706","article-title":"Critical Review of Bone Health, Fracture Risk and Management of Bone Fragility in Diabetes Mellitus","volume":"12","author":"Palui","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"111378","DOI":"10.1016\/j.exger.2021.111378","article-title":"Risk of Non-Vertebral Fractures in Men with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cohort Studies","volume":"150","author":"Gao","year":"2021","journal-title":"Exp. Gerontol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","article-title":"The Risk of Hip and Non-Vertebral Fractures in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis Update","volume":"137","author":"Vilaca","year":"2020","journal-title":"Bone"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"116880","DOI":"10.1016\/j.bone.2023.116880","article-title":"Advanced Glycation and Glycoxidation End Products in Bone","volume":"176","author":"Wang","year":"2023","journal-title":"Bone"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"106198","DOI":"10.1016\/j.jmbbm.2023.106198","article-title":"Advanced-Glycation Endproducts: How Cross-Linking Properties Affect the Collagen Fibril Behavior","volume":"148","author":"Kamml","year":"2023","journal-title":"J. Mech. Behav. Biomed. Mater."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11010-007-9557-8","article-title":"Regulation of Advanced Glycation End Product (AGE) Receptors and Apoptosis by AGEs in Osteoblast-Like Cells","volume":"306","author":"Mercer","year":"2007","journal-title":"Mol. Cell. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Umur, E., Bulut, S.B., Yi\u011fit, P., Bayrak, E., Arkan, Y., Arslan, F., Baysoy, E., Kaleli-Can, G., and Ayan, B. (2024). Exploring the Role of Hormones and Cytokines in Osteoporosis Development. Biomedicines, 12.","DOI":"10.3390\/biomedicines12081830"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Khalid, M., Petroianu, G., and Adem, A. (2022). Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives. Biomolecules, 12.","DOI":"10.3390\/biom12040542"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"975872","DOI":"10.1155\/2014\/975872","article-title":"Advanced Glycation End Products Play Adverse Proinflammatory Activities in Osteoporosis","volume":"2014","author":"Sanguineti","year":"2014","journal-title":"Mediat. Inflamm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2337\/diabetes.55.02.06.db05-1201","article-title":"Diabetes Enhances mRNA Levels of Proapoptotic Genes and Caspase Activity, which Contribute to Impaired Healing","volume":"55","author":"Kandru","year":"2006","journal-title":"Diabetes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2174\/0113895575344980250130062547","article-title":"The Role of Renin-Angiotensin System in Diabetic Nephropathy: An Update","volume":"25","author":"Sanglard","year":"2025","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Mkhize, B.C., Mosili, P., Ngubane, P.S., Sibiya, N.H., and Khathi, A. (2023). The Relationship between Renin-Angiotensin-Aldosterone System (RAAS) Activity, Osteoporosis and Estrogen Deficiency in Type 2 Diabetes. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241511963"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1271\/bbb.120123","article-title":"Involvement of the Skeletal Renin-Angiotensin System in Age-Related Osteoporosis of Ageing Mice","volume":"76","author":"Gu","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s00774-020-01132-y","article-title":"Role of the Renin-Angiotensin-Aldosterone System in Bone Metabolism","volume":"38","author":"Mo","year":"2020","journal-title":"J. Bone Miner. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/HYPERTENSIONAHA.115.06837","article-title":"Association of Circulating Renin and Aldosterone with Osteocalcin and Bone Mineral Density in African Ancestry Families","volume":"67","author":"Kuipers","year":"2016","journal-title":"Hypertension"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7581110","DOI":"10.1155\/2022\/7581110","article-title":"Angiotensin Receptor Blocker is Associated with a Lower Fracture Risk: An Updated Systematic Review and Meta-Analysis","volume":"2022","author":"Wu","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and Management of Bone Fragility in Diabetes: An Emerging Challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s11914-023-00828-0","article-title":"The Differential Effect of Metformin on Osteocytes, Osteoblasts, and Osteoclasts","volume":"21","author":"Kleemann","year":"2023","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Daniilopoulou, I., Vlachou, E., Lambrou, G.I., Ntikoudi, A., Dokoutsidou, E., Fasoi, G., Govina, O., Kavga, A., and Tsartsalis, A.N. (2022). The Impact of GLP1 Agonists on Bone Metabolism: A Systematic Review. Medicina, 58.","DOI":"10.3390\/medicina58020224"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.maturitas.2021.12.003","article-title":"GLP-1RAs for the Treatment of Obesity in Women After Menopause","volume":"156","author":"Paschou","year":"2022","journal-title":"Maturitas"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ye, Y., Zhao, C., Liang, J., Yang, Y., Yu, M., and Qu, X. (2019). Effect of Sodium-Glucose Co-Transporter 2 Inhibitors on Bone Metabolism and Fracture Risk. Front. Pharmacol., 9.","DOI":"10.3389\/fphar.2018.01517"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of Canagliflozin on Fracture Risk in Patients with Type 2 Diabetes Mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Azhari, H.F., and Dawson, J. (2025). Clinical Implications of Fracture Severity Risk with Pioglitazone: A Systematic Review and Meta-Analysis of Clinical Randomized Trials. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1357309"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e10522","DOI":"10.1002\/jbm4.10522","article-title":"Cardiovascular Safety of Antifracture Medications in Patients with Osteoporosis: A Narrative Review of Evidence from Randomized Studies","volume":"5","author":"Rodriguez","year":"2021","journal-title":"JBMR Plus"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e004344","DOI":"10.1161\/JAHA.116.004344","article-title":"Bone Mineral Density and Risk of Heart Failure in Older Adults: The Cardiovascular Health Study","volume":"6","author":"Fohtung","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/jbmr.3089","article-title":"Relationship between Low Bone Mineral Density and Fractures with Incident Cardiovascular Disease: A Systematic Review and Meta-Analysis","volume":"32","author":"Veronese","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00198-019-04966-z","article-title":"Increased Risk of Osteoporotic Vertebral Fracture in Rheumatoid Arthritis Patients with New-Onset Cardiovascular Diseases: A Retrospective Nationwide Cohort Study in Taiwan","volume":"30","author":"Hong","year":"2019","journal-title":"Osteoporos. Int."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11914-012-0115-2","article-title":"Heart Failure as a Risk Factor for Osteoporosis and Fractures","volume":"10","author":"Aluoch","year":"2012","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jcsm.12516","article-title":"Bone in Heart Failure","volume":"11","author":"Loncar","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Liu, X., Jian, X., Liang, D., Wen, J., Wei, Y., Wu, J., and Li, Y. (2022). The Association between Heart Failure and Risk of Fractures: Pool Analysis Comprising 260,410 Participants. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.977082"},{"key":"ref_57","first-page":"673","article-title":"Cardiovascular Disease and Osteoporosis: Balancing Risk Management","volume":"3","author":"Warburton","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1161\/01.CIR.0000127957.43874.BB","article-title":"Osteoprotegerin is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease","volume":"109","author":"Kiechl","year":"2004","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1186\/s13018-023-04179-5","article-title":"The Association of Osteoprotegerin and RANKL with Osteoporosis: A Systematic Review with Meta-Analysis","volume":"18","author":"Chi","year":"2023","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.M800021200","article-title":"Oxidative Stress Induces Vascular Calcification through Modulation of the Osteogenic Transcription Factor Runx2 by AKT Signaling","volume":"283","author":"Byon","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"209","DOI":"10.11138\/ccmbm\/2017.14.1.209","article-title":"Oxidative Stress in Bone Remodeling: Role of Antioxidants","volume":"14","author":"Domazetovic","year":"2017","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Qiao, Y. (2022). Reactive Oxygen Species in Cardiovascular Calcification: Role of Medicinal Plants. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.858160"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.1073\/pnas.1932554100","article-title":"Calcification in Atherosclerosis: Bone Biology and Chronic Inflammation at the Arterial Crossroads","volume":"100","author":"Doherty","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/hh2101.099270","article-title":"Novel Clinical Markers of Vascular Wall Inflammation","volume":"89","author":"Blake","year":"2001","journal-title":"Circ. Res."},{"key":"ref_65","first-page":"2077","article-title":"Signaling Pathways Involved in Vascular Smooth Muscle Cell Calcification during Hyperphosphatemia","volume":"76","author":"Voelkl","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1152\/ajpcell.00248.2015","article-title":"The Vascular Ca2+-Sensing Receptor Regulates Blood Vessel Tone and Blood Pressure","volume":"310","author":"Schepelmann","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Alves, R.D.A.M., Eijken, M., van de Peppel, J., and van Leeuwen, J.P.T.M. (2014). Calcifying Vascular Smooth Muscle Cells and Osteoblasts: Independent Cell Types Exhibiting Extracellular Matrix and Biomineralization-Related Mimicries. BMC Genom., 15.","DOI":"10.1186\/1471-2164-15-965"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4248\/BR201303001","article-title":"The Key Role of the Blood Supply to Bone","volume":"1","author":"Marenzana","year":"2013","journal-title":"Bone Res."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ren, J., Marahleh, A., Ma, J., Ohori, F., Noguchi, T., Fan, Z., Hu, J., Narita, K., Lin, A., and Kitaura, H. (2025). Angiotensin II Promotes Osteocyte RANKL Expression Via AT1R Activation. Biomedicines, 13.","DOI":"10.3390\/biomedicines13020426"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamainternmed.2024.0507","article-title":"Antihypertensive Medication and Fracture Risk in Older Veterans Health Administration Nursing Home Residents","volume":"184","author":"Dave","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/HYPERTENSIONAHA.123.21648","article-title":"Advanced Progress of the Relationship between Antihypertensive Drugs and Bone Metabolism","volume":"80","author":"Zhang","year":"2023","journal-title":"Hypertension"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with Beta-Blockers, ACE Inhibitors, and Calcium-Channel Blockers is Associated with a Reduced Fracture Risk: A Nationwide Case-Control Study","volume":"24","author":"Rejnmark","year":"2006","journal-title":"J. Hypertens."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2015.01.072","article-title":"Risk of Fractures in Subjects with Antihypertensive Medications: A Nationwide Claim Study","volume":"184","author":"Choi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/jama.292.11.1326","article-title":"Use of Beta-Blockers and Risk of Fractures","volume":"292","author":"Schlienger","year":"2004","journal-title":"JAMA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"afab264","DOI":"10.1093\/ageing\/afab264","article-title":"Fracture Risks in Patients with Atrial Fibrillation Treated with Different Oral Anticoagulants: A Meta-Analysis and Systematic Review","volume":"51","author":"Xie","year":"2022","journal-title":"Age Ageing"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00198-014-2662-0","article-title":"Incident Long-Term Warfarin use and Risk of Osteoporotic Fractures: Propensity-Score Matched Cohort of Elders with New Onset Atrial Fibrillation","volume":"25","author":"Misra","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"471","DOI":"10.7150\/ijms.39523","article-title":"Association between Oral Anticoagulants and Osteoporosis: Real-World Data Mining using a Multi-Methodological Approach","volume":"17","author":"Yokoyama","year":"2020","journal-title":"Int. J. Med. Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"152304","DOI":"10.1016\/j.semarthrit.2023.152304","article-title":"Cardiovascular Safety of Zoledronic Acid in the Treatment of Primary Osteoporosis: A Meta-Analysis and Systematic Review","volume":"64","author":"Liu","year":"2024","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jbmr.4911","article-title":"Electrocardiogram Changes Following Intravenous Bisphosphonate Infusion: A Systematic Review and Meta-Analysis","volume":"38","author":"Shoung","year":"2023","journal-title":"J. Bone Miner. Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Grosso, A., Douglas, I., Hingorani, A., MacAllister, R., and Smeeth, L. (2009). Oral Bisphosphonates and Risk of Atrial Fibrillation and Flutter in Women: A Self-Controlled Case-Series Safety Analysis. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0004720"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0735-1097(23)00530-2","article-title":"A Real-World Disproportionality Analysis of Atrial Fibrillation Adverse Events Associated with Bisphosphonates","volume":"81","author":"Thakre","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab Or Alendronate for Fracture Prevention in Women with Osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab Treatment in Postmenopausal Women with Osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s40264-024-01475-9","article-title":"Cardiovascular Safety of Romosozumab Compared to Commonly used Anti-Osteoporosis Medications in Postmenopausal Osteoporosis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials","volume":"48","author":"Cheng","year":"2025","journal-title":"Drug Saf."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women\u2019s Health Initiative Randomized Controlled Trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women. Heart and Estrogen\/Progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley","year":"1998","journal-title":"JAMA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.numecd.2021.12.023","article-title":"Malnutrition in Patients with Coronary Artery Disease: Prevalence and Mortality in a 46,485 Chinese Cohort Study","volume":"32","author":"Liu","year":"2022","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Lv, S., and Ru, S. (2021). The Prevalence of Malnutrition and its Effects on the all-Cause Mortality among Patients with Heart Failure: A Systematic Review and Meta-Analysis. PLoS ONE, 16.","DOI":"10.37766\/inplasy2021.6.0063"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2891-8-6","article-title":"Nutrient Intakes Related to Osteoporotic Fractures in Men and Women--the Brazilian Osteoporosis Study (BRAZOS)","volume":"8","author":"Pinheiro","year":"2009","journal-title":"Nutr. J."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Chiavarini, M., Ricciotti, G.M., Genga, A., Faggi, M.I., Rinaldi, A., Toscano, O.D., D\u2019Errico, M.M., and Barbadoro, P. (2024). Malnutrition-Related Health Outcomes in Older Adults with Hip Fractures: A Systematic Review and Meta-Analysis. Nutrients, 16.","DOI":"10.3390\/nu16071069"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Zeller, T., Waldeyer, C., Ojeda, F., Schnabel, R.B., Schafer, S., Altay, A., Lackner, K.J., Anker, S.D., Westermann, D., and Blankenberg, S. (2018). Adverse Outcome Prediction of Iron Deficiency in Patients with Acute Coronary Syndrome. Biomolecules, 8.","DOI":"10.3390\/biom8030060"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cardfail.2023.03.025","article-title":"Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America","volume":"29","author":"Beavers","year":"2023","journal-title":"J. Card. Fail."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Pan, M., Chen, L., Tsao, H., and Chen, K. (2017). Iron Deficiency Anemia as a Risk Factor for Osteoporosis in Taiwan: A Nationwide Population-Based Study. Nutrients, 9.","DOI":"10.20944\/preprints201704.0053.v1"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1111\/j.1532-5415.2010.03183.x","article-title":"The Relationship between Incidence of Fractures and Anemia in Older Multiethnic Women","volume":"58","author":"Chen","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11914-024-00892-0","article-title":"Nutrition and Osteoporosis Prevention","volume":"22","author":"Rizzoli","year":"2024","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1194\/jlr.R031534","article-title":"Cytochrome P450-Mediated Metabolism of Vitamin D","volume":"55","author":"Jones","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JCN.0000000000000521","article-title":"Dietary Vitamin C Deficiency is Associated with Health-Related Quality of Life and Cardiac Event-Free Survival in Adults with Heart Failure","volume":"34","author":"Wu","year":"2019","journal-title":"J. Cardiovasc. Nurs."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/JCN.0000000000000389","article-title":"Vitamin C Deficiency, High-Sensitivity C-Reactive Protein, and Cardiac Event-Free Survival in Patients with Heart Failure","volume":"33","author":"Song","year":"2018","journal-title":"J. Cardiovasc. Nurs."},{"key":"ref_99","unstructured":"Glorieux, F.H., Pettifor, J.M., and J\u00fcppner, H. (2012). Chapter 29\u2014Chronic Kidney Disease Mineral and Bone Disorder. Pediatric Bone, Academic Press. [2nd ed.]."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"i3","DOI":"10.1093\/ckj\/sfae431","article-title":"Pathophysiology of Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD): From Adaptive to Maladaptive Mineral Homeostasis","volume":"18","author":"Salera","year":"2025","journal-title":"Clin. Kidney J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacbts.2020.02.002","article-title":"Targeting Vascular Calcification in Chronic Kidney Disease","volume":"5","author":"Nelson","year":"2020","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Tsiftsoglou, A.S. (2021). Erythropoietin (EPO) as a Key Regulator of Erythropoiesis, Bone Remodeling and Endothelial Transdifferentiation of Multipotent Mesenchymal Stem Cells (MSCs): Implications in Regenerative Medicine. Cells, 10.","DOI":"10.3390\/cells10082140"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Landau, D., London, L., Bandach, I., and Segev, Y. (2018). The Hypoxia Inducible Factor\/Erythropoietin (EPO)\/EPO Receptor Pathway is Disturbed in a Rat Model of Chronic Kidney Disease Related Anemia. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196684"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zhang, Z.X., Fu, C.S., Ye, Z.B., Jin, H.M., and Yang, X.H. (2025). Association of Aberrant Mineral Metabolic Markers with Fracture Risk in Chronic Kidney Disease: A Comprehensive Meta-Analysis. BMC Nephrol., 26.","DOI":"10.1186\/s12882-025-03992-w"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00198-023-06817-4","article-title":"Update on the Clinical use of Trabecular Bone Score (TBS) in the Management of Osteoporosis: Results of an Expert Group Meeting Organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), and the International Osteoporosis Fation (IOF) Under the Auspices of WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging","volume":"34","author":"Shevroja","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long-Term use of Thiazolidinediones and Fractures in Type 2 Diabetes: A Meta-Analysis","volume":"180","author":"Loke","year":"2009","journal-title":"CMAJ"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e12492","DOI":"10.1111\/opn.12492","article-title":"What is the Impact of Daily Oral Supplementation of Vitamin D3 (Cholecalciferol) Plus Calcium on the Incidence of Hip Fracture in Older People? A Systematic Review and Meta-Analysis","volume":"18","author":"Manoj","year":"2023","journal-title":"Int. J. Older People Nurs."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"156052","DOI":"10.1016\/j.metabol.2024.156052","article-title":"Advances in Body Composition and Gender Differences in Susceptibility to Frailty Syndrome: Role of Osteosarcopenic Obesity","volume":"161","author":"Conforto","year":"2024","journal-title":"Metabolism"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1053\/j.ajkd.2021.06.031","article-title":"Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review","volume":"79","author":"Ginsberg","year":"2022","journal-title":"Am. J. Kidney Dis."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s12020-014-0280-4","article-title":"Utility of the Trabecular Bone Score (TBS) in Secondary Osteoporosis","volume":"47","author":"Ulivieri","year":"2014","journal-title":"Endocrine"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2169\/internalmedicine.8618-16","article-title":"Management of Osteoporosis in Chronic Kidney Disease","volume":"56","author":"Nitta","year":"2017","journal-title":"Intern. Med."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Aguilar, A., Gifre, L., Urena-Torres, P., Carrillo-Lopez, N., Rodriguez-Garcia, M., Masso, E., da Silva, I., Lopez-Baez, V., Sanchez-Baya, M., and Prior-Espanol, A. (2023). Pathophysiology of Bone Disease in Chronic Kidney Disease: From Basics to Renal Osteodystrophy and Osteoporosis. Front. Physiol., 14.","DOI":"10.3389\/fphys.2023.1177829"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"b2803","DOI":"10.1136\/bmj.b2803","article-title":"We Need Minimally Disruptive Medicine","volume":"339","author":"May","year":"2009","journal-title":"BMJ"},{"key":"ref_115","unstructured":"World Health Organization (2017). Integrated care for older people: Guidelines on community-level interventions to manage declines in intrinsic capacity, Integrated Care for Older People: Guidelines on Community-Level Interventions to Manage Declines in Intrinsic Capacity."},{"key":"ref_116","unstructured":"Action, A.J. (2025, November 02). Managing Frailty. A Comprehensive Approach to Promote Disability-Free Advanced Age in Europe: The ADVANTAGE Initiative. Available online: https:\/\/publichealth.ro\/project\/advantage\/."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"afaf017","DOI":"10.1093\/ageing\/afaf017","article-title":"Effects of Osteoporosis Treatment and Multicomponent Integrated Care on Intrinsic Capacity and Happiness among Rural Community-Dwelling Older Adults: The Healthy Longevity and Ageing in Place (HOPE) Randomised Controlled Trial","volume":"54","author":"Chang","year":"2025","journal-title":"Age Ageing"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11657-022-01171-0","article-title":"The Interdisciplinary Fracture Liaison Service Improves Health-Related Outcomes and Survival of Older Adults After Hip Fracture Surgical Repair","volume":"17","author":"Ruggiero","year":"2022","journal-title":"Arch. Osteoporos."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Huang, T., Li, C., Chen, F., Xie, D., Yang, C., Chen, Y., Wang, J., Li, J., and Zheng, F. (2023). Prevalence and Risk Factors of Osteosarcopenia: A Systematic Review and Meta-Analysis. BMC Geriatr., 23.","DOI":"10.1186\/s12877-023-04085-9"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Okayama, A., Nakayama, N., Kashiwa, K., Horinouchi, Y., Fukusaki, H., Nakamura, H., and Katayama, S. (2022). Prevalence of Sarcopenia and its Association with Quality of Life, Postural Stability, and Past Incidence of Falls in Postmenopausal Women with Osteoporosis: A Cross-Sectional Study. Healthcare, 10.","DOI":"10.3390\/healthcare10020192"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"352","DOI":"10.12701\/jyms.2023.00724","article-title":"Multidisciplinary Approach to Sarcopenia: A Narrative Review","volume":"40","author":"Park","year":"2023","journal-title":"J. Yeungnam Med. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"254","DOI":"10.14283\/jfa.2021.3","article-title":"Impact of Social Frailty on Relocation of Older Adults","volume":"10","author":"Bigonnesse","year":"2021","journal-title":"J. Frailty Aging"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1759720X221083523","DOI":"10.1177\/1759720X221083523","article-title":"Digital Health Interventions for Osteoporosis and Post-Fragility Fracture Care","volume":"14","author":"Gupta","year":"2022","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3899\/jrheum.161529","article-title":"Improving Access to Rheumatologists: Use and Benefits of an Electronic Consultation Service","volume":"45","author":"Rostom","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00223-014-9849-4","article-title":"Osteoporosis Screening and Treatment among Veterans with Recent Fracture After Implementation of an Electronic Consult Service","volume":"94","author":"Lee","year":"2014","journal-title":"Calcif. Tissue Int."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40674-022-00195-4","article-title":"Remote Management of Osteoporosis","volume":"8","author":"Saag","year":"2022","journal-title":"Curr. Treat. Opt. Rheumatol."},{"key":"ref_127","first-page":"19","article-title":"The Link between Osteoporosis and Cardiovascular Disease","volume":"5","author":"Farhat","year":"2008","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"105580","DOI":"10.1016\/j.ebiom.2025.105580","article-title":"Cardio-Metabolic-Related Plasma Proteins Reveal Biological Links between Cardiovascular Diseases and Fragility Fractures: A Cohort and Mendelian Randomisation Investigation","volume":"113","author":"Michaelsson","year":"2025","journal-title":"EBioMedicine"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1001\/jama.2009.1463","article-title":"Cardiovascular Diseases and Risk of Hip Fracture","volume":"302","author":"Sennerby","year":"2009","journal-title":"JAMA"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2796.2004.01434.x","article-title":"Effects of Long-Term Treatment with Loop Diuretics on Bone Mineral Density, Calcitropic Hormones and Bone Turnover","volume":"257","author":"Rejnmark","year":"2005","journal-title":"J. Intern. Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Lin, S., Yang, S., Wang, C., and Huang, H. (2019). Association between Diuretic use and the Risk of Vertebral Fracture After Stroke: A Population-Based Retrospective Cohort Study. BMC Musculoskelet. Disord., 20.","DOI":"10.1186\/s12891-019-2471-x"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00198-023-06742-6","article-title":"Development, Implementation and Evaluation of a Multinational FLS Mentorship Programme in Latin America","volume":"34","author":"Javaid","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s44158-025-00291-6","article-title":"An Interpretable Machine Learning Tool for Predicting Perioperative Cardiac Events in Patients Scheduled for Hip Fracture Surgery: Insights from the Multicenter LUSHIP Study","volume":"5","author":"Azzolina","year":"2025","journal-title":"J. Anesth. Analg. Crit. Care"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/2\/262\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T12:06:39Z","timestamp":1768392399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/2\/262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":133,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["nu18020262"],"URL":"https:\/\/doi.org\/10.3390\/nu18020262","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]}}}